Researchers from the IDIBELL and the Vall d'Hebron Research Institute (VHIR) have shown that administration of genetically modified mesenchymal stem cells regenerates lung tissue and stops the inflammatory process in mice with acute lung injury.

Researchers of the Bellvitge Biomedical Research Institute (IDIBELL), led by Manel Esteller, director of the Epigenetics and Cancer Biology Program, , describe in the online edition of the journal Oncogene how an epigenetic modification triggers a dimensional change in the nucleus cell to form spherical structures that block the function of antitumor genes.